1. Home
  2. CYTH vs IZM Comparison

CYTH vs IZM Comparison

Compare CYTH & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTH
  • IZM
  • Stock Information
  • Founded
  • CYTH 1990
  • IZM 2011
  • Country
  • CYTH United States
  • IZM China
  • Employees
  • CYTH N/A
  • IZM N/A
  • Industry
  • CYTH Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • CYTH Health Care
  • IZM Consumer Discretionary
  • Exchange
  • CYTH Nasdaq
  • IZM Nasdaq
  • Market Cap
  • CYTH 26.2M
  • IZM 23.7M
  • IPO Year
  • CYTH N/A
  • IZM 2023
  • Fundamental
  • Price
  • CYTH $0.80
  • IZM $1.45
  • Analyst Decision
  • CYTH Buy
  • IZM
  • Analyst Count
  • CYTH 3
  • IZM 0
  • Target Price
  • CYTH $0.95
  • IZM N/A
  • AVG Volume (30 Days)
  • CYTH 52.2K
  • IZM 71.6K
  • Earning Date
  • CYTH 03-17-2025
  • IZM 01-29-2025
  • Dividend Yield
  • CYTH N/A
  • IZM N/A
  • EPS Growth
  • CYTH N/A
  • IZM N/A
  • EPS
  • CYTH N/A
  • IZM N/A
  • Revenue
  • CYTH $870,725.00
  • IZM $177,933,890.00
  • Revenue This Year
  • CYTH N/A
  • IZM N/A
  • Revenue Next Year
  • CYTH $24.49
  • IZM N/A
  • P/E Ratio
  • CYTH N/A
  • IZM N/A
  • Revenue Growth
  • CYTH N/A
  • IZM N/A
  • 52 Week Low
  • CYTH $0.55
  • IZM $1.44
  • 52 Week High
  • CYTH $2.12
  • IZM $52.21
  • Technical
  • Relative Strength Index (RSI)
  • CYTH 70.05
  • IZM 22.57
  • Support Level
  • CYTH $0.76
  • IZM $1.44
  • Resistance Level
  • CYTH $0.86
  • IZM $1.80
  • Average True Range (ATR)
  • CYTH 0.07
  • IZM 0.09
  • MACD
  • CYTH 0.03
  • IZM -0.01
  • Stochastic Oscillator
  • CYTH 92.58
  • IZM 13.19

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: